Evidence map›Paper›PMID 38755724›Full record

ArticleZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2024

Expression pattern of the bone morphogenetic protein-4 and its relationship with inflammation, vascular injury in patients suffered the arterial occlusive diseases.

Wenjuan Zhang, Min Hu, Lin Yang, Zhifang Zhou, Ruohong Chen, Zhaoyang Liu

Abstract read
In one paragraph

Article in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wenjuan ZhangDepartment of Laboratory, Second Xiangya Hospital, Central South University, Changsha 410011. akkc-wj@163.com.
Min HuDepartment of Laboratory, Second Xiangya Hospital, Central South University, Changsha 410011.
Lin YangDepartment of Anesthesiology, Second Xiangya Hospital, Central South University, Changsha 410011.
Zhifang ZhouDepartment of Laboratory, Second Xiangya Hospital, Central South University, Changsha 410011.
Ruohong ChenDepartment of Laboratory, Second Xiangya Hospital, Central South University, Changsha 410011. chenruohong@csu.edu.cn.
Zhaoyang LiuDepartment of Laboratory, Second Xiangya Hospital, Central South University, Changsha 410011. liuzhaoyang4008@csu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesBone morphogenetic protein-4 (BMP4) has been proved to be an important regulatory factor for the pathological process of atherosclerosis (AS). However, there are few related clinical studies. This study aims to investigate the levels of plasma BMP4 in patients suffering from the arterial occlusive diseases (ACD) characterized by AS, and further to test the relationship between BMP4 and inflammation and vascular injury.

methodsA total of 38 ACD patients (the ACD group) and 38 healthy people for the physical examination (the control group) were enrolled. The plasma in each subject from both groups was obtained to test the levels of BMP4, tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), IL-10, and vascular endothelial cadherin (VE-cadherin), and the relationship between BMP4 and the detected indicators above were further analyzed.

resultsCompared with the control group, the patients in the ACD group displayed significant elevations in the neutrophil to lymphocyte ratio [NLR, 1.63 (1.26, 1.91) vs 3.43 (2.16, 6.61)] and platelet to lymphocyte ratio [PLR, 6.37 (5.26, 7.74) vs 15.79 (7.97, 20.53)], while decrease in the lymphocyte to monocyte ratio [LMR, 5.67 (4.41, 7.14) vs 3.43 (2.07, 3.74)] (all

conclusionsAfter ACD occurrence, the patients' plasma concentrations of BMP4 would be upregulated, which may serve as a candidate to indicate the levels of inflammation and vascular injury.

Indexed as

Arterial Occlusive DiseasesBone Morphogenetic Protein 4InflammationInterleukin-10Tumor Necrosis Factor-alphaAntigens, CDAtherosclerosisCadherin 5CadherinsCase-Control StudiesFemaleHumansInterleukin-1betaLymphocytesMaleNeutrophilsAntigens, CDBMP4 protein, humanBone Morphogenetic Protein 4Cadherin 5CadherinsIL10 protein, humanIL1B protein, humanInterleukin-10Interleukin-1betaTumor Necrosis Factor-alphaarterial occlusive diseasebone morphogenetic protein-4inflammationvascular injury

Identifiers

PMID38755724
PMCPMC11103063

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.